Ulti_1170x120_5-11-20

Takeda Digital Ventures

Biofourmis expands into oncology market with acquisition of Gaido Health

Biofourmis expands into oncology market with acquisition of Gaido Health

BOSTON – Biofourmis, a global leader in digital therapeutics that powers personalized predictive care, announced today it has finalized an agreement to acquire Gaido Health from Takeda Pharmaceuticals, a strategic deal that expands Biofourmis’ portfolio in the oncology space. Gaido Health—a Los Angeles-area based digital therapeutics company focused on the oncology market—was part of Takeda